This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004 Nov;86(11):2575.

doi: 10.2106/00004623-200411000-00051.

Olpadronate reduced fractures in children with osteogenesis imperfecta

William G Cole¹

Affiliations

PMID: 15523042
DOI: 10.2106/00004623-200411000-00051

Comment

Olpadronate reduced fractures in children with osteogenesis imperfecta

William G Cole. J Bone Joint Surg Am. 2004 Nov.

. 2004 Nov;86(11):2575.

doi: 10.2106/00004623-200411000-00051.

Author

William G Cole¹

Affiliation

¹ The Hospital for Sick Children, University of Toronto,Toronto, Ontario, Canada.

PMID: 15523042
DOI: 10.2106/00004623-200411000-00051

No abstract available

PubMed Disclaimer

Comment on

Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study.
Sakkers R, Kok D, Engelbert R, van Dongen A, Jansen M, Pruijs H, Verbout A, Schweitzer D, Uiterwaal C. Sakkers R, et al. Lancet. 2004 May 1;363(9419):1427-31. doi: 10.1016/S0140-6736(04)16101-1. Lancet. 2004. PMID: 15121405 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer